FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to solid dispersion capable of inhibiting ErbB2, pharmaceutical composition containing this solid dispersion, method of treating cancer, and application of composition for treating cancer. Solid dispersion contains amorphous N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and a dispersion polymer.
EFFECT: implementation of the invention will increase pharmacokinetics of the active substance.
51 cl, 6 tbl, 18 ex, 13 dwg
Title | Year | Author | Number |
---|---|---|---|
POLYMORPHS OF ARRY-380, SELECTIVE INHIBITOR OF ERB2, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2012 |
|
RU2629116C2 |
TREATMENT OF BRAIN CANCER | 2013 |
|
RU2672575C2 |
INHIBITORS OF TYPE ErbB INHIBITORS | 2006 |
|
RU2592703C9 |
N4-PHENYLQUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS RECEPTOR TYROSINE KINASE TYPE ERBB INIHIBITORS FOR TREATING HYPERPROLIFERATIVE DISEASES | 2006 |
|
RU2428421C2 |
HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | 2013 |
|
RU2671628C2 |
KINASE INHIBITORS | 2013 |
|
RU2637944C2 |
AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF LEUCINE-REPEATING KINASE 2 | 2013 |
|
RU2637947C2 |
THERAPEUTICALLY ACTIVE DERIVATIVES OF OXAZOLINE | 2013 |
|
RU2656209C2 |
SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
Authors
Dates
2018-03-26—Published
2012-10-12—Filed